Annual Total Expenses
$221.02 M
+$89.73 M+68.34%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual total expenses is $221.02 million, with the most recent change of +$89.73 million (+68.34%) on December 31, 2023.
- During the last 3 years, INBX annual total expenses has risen by +$140.77 million (+175.41%).
- INBX annual total expenses is now at all-time high.
Performance
INBX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$46.80 M
-$114.20 M-70.93%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly total expenses is $46.80 million, with the most recent change of -$114.20 million (-70.93%) on September 30, 2024.
- Over the past year, INBX quarterly total expenses has dropped by -$114.20 million (-70.93%).
- INBX quarterly total expenses is now -70.93% below its all-time high of $161.00 million, reached on June 30, 2024.
Performance
INBX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
INBX Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +68.3% | -70.9% |
3 y3 years | +175.4% | +18.4% |
5 y5 years | +497.1% | +18.4% |
INBX Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +164.1% | -70.9% | +110.4% |
5 y | 5-year | at high | +318.5% | -70.9% | +179.9% |
alltime | all time | at high | +698.5% | -70.9% | +410.2% |
Inhibrx Biosciences Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $46.80 M(-70.9%) |
Jun 2024 | - | $161.00 M(+227.1%) |
Mar 2024 | - | $49.21 M(+111.4%) |
Dec 2023 | $221.02 M(+68.3%) | $23.28 M(-49.3%) |
Sep 2023 | - | $45.95 M(+11.1%) |
Jun 2023 | - | $41.37 M(+4.6%) |
Mar 2023 | - | $39.54 M(+10.5%) |
Dec 2022 | $131.29 M(+56.9%) | $35.77 M(+18.1%) |
Sep 2022 | - | $30.28 M(-14.2%) |
Jun 2022 | - | $35.31 M(+18.0%) |
Mar 2022 | - | $29.93 M(+34.6%) |
Dec 2021 | $83.69 M | $22.24 M(+4.4%) |
Sep 2021 | - | $21.31 M(+2.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | $20.72 M(+6.7%) |
Mar 2021 | - | $19.42 M(-2.3%) |
Dec 2020 | $80.25 M(+52.0%) | $19.88 M(-7.0%) |
Sep 2020 | - | $21.38 M(+4.3%) |
Jun 2020 | - | $20.50 M(+10.9%) |
Mar 2020 | - | $18.48 M(+10.5%) |
Dec 2019 | $52.81 M(+42.7%) | $16.72 M(+20.8%) |
Sep 2019 | - | $13.84 M(+19.3%) |
Jun 2019 | - | $11.60 M(+9.0%) |
Mar 2019 | - | $10.64 M(+16.0%) |
Dec 2018 | $37.01 M(+33.7%) | - |
Jun 2018 | - | $9.17 M(-19.5%) |
Mar 2018 | - | $11.40 M |
Dec 2017 | $27.68 M | - |
FAQ
- What is Inhibrx Biosciences annual total expenses?
- What is the all time high annual total expenses for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual total expenses year-on-year change?
- What is Inhibrx Biosciences quarterly total expenses?
- What is the all time high quarterly total expenses for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly total expenses year-on-year change?
What is Inhibrx Biosciences annual total expenses?
The current annual total expenses of INBX is $221.02 M
What is the all time high annual total expenses for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual total expenses is $221.02 M
What is Inhibrx Biosciences annual total expenses year-on-year change?
Over the past year, INBX annual total expenses has changed by +$89.73 M (+68.34%)
What is Inhibrx Biosciences quarterly total expenses?
The current quarterly total expenses of INBX is $46.80 M
What is the all time high quarterly total expenses for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly total expenses is $161.00 M
What is Inhibrx Biosciences quarterly total expenses year-on-year change?
Over the past year, INBX quarterly total expenses has changed by -$114.20 M (-70.93%)